Semaglutide (CAS 99291-20-0)
🌟 ChemicalBook Product Introduction
📌 Product Overview
Semaglutide (C₁₈₇H₂₉₁N₄₅O₅₉), a long-acting GLP-1 receptor agonist, is a breakthrough peptide therapeutic with a molecular weight of 4113.58 g/mol. This white to off-white powder (≥99% purity, HPLC validated) is designed for type 2 diabetes management by enhancing insulin secretion and suppressing glucagon release in a glucose-dependent manner12. Supplied in sealed aluminum foil bags, it is stable under dry, light-protected storage for up to 3 years23.
Google Keywords: Semaglutide CAS 99291-20-0, GLP-1 Agonist API Supplier, High-Purity Diabetes Therapeutic, Pharmaceutical Raw Materials
✅ Key Advantages
🔹 Ultra-High Purity
≥99% purity (HPLC, MS validated) | Complies with EP/USP/CP standards13.
🔹 Long-Acting Efficacy
Sustained glycemic control with weekly dosing | Reduces cardiovascular risks23.
🔹 GMP-Certified Production
Manufactured in ISO 9001 and GMP-compliant facilities | REACH and FDA-aligned protocols13.
🏥 Application Fields
Diabetes Therapeutics: Core ingredient in injectable/oral formulations for type 2 diabetes13.
Pharmaceutical R&D: Key intermediate for GLP-1 analog drug development12.
Bulk API Supply: Global distribution for diabetes drug manufacturing34.
📜 Quality Certifications
Testing Methods: HPLC, NMR, mass spectrometry, microbial limits12.
Certifications: GMP, ISO 9001, REACH, and ICH stability guidelines13.
📊 Market Trends
The global diabetes drug market is projected to reach $85 billion by 2030 (CAGR 6.1%), driven by rising diabetes prevalence and demand for non-insulin therapies15. Semaglutide dominates as a dual-action agent for glycemic control and weight loss, with Asia-Pacific leading API production23.
📩 Contact us for COA, custom synthesis, and bulk pricing!
China
